AFT Pharmaceuticals to announce full year results on Monday

4 May 2023
AFT Pharmaceuticals to announce full year results on Monday May 22 2023
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release
on Monday May 22 2023 its full year results for the year ended March 31 2023. The
release will be issued at around 09:00.
T
his will be followed by a presentation by management at 10:00 by teleconference.
The presentation material which will be referred to by management will be issued at
around 09:00 and will also be available on the company’s website aftpharm.com.
T
o attend the conference call you will need to use the pre-registration link below.
Once you have completed this you will be provided with dial in details and a unique
pin code.
R
egistration Link: AFT results presentation FY2023
F
or and on behalf of AFT Pharmaceuticals Limited, Malcolm Tubby, CFO.
F
or more information:
I
nvestors Media
Malcolm Tubby Richard Inder
CFO, AFT Pharmaceuticals Ltd The Project
Phone: +64 9 488 0232 Phone: 021 645 643
Email: malcolm@aftpharm.com Email: richard@theproject.co.nz
A
bout AFT Pharmaceuticals
AFT is a growing multinational pharmaceutical company that develops, markets and
distributes a broad portfolio of pharmaceutical products across a wide range of
therapeutic categories which are distributed across all major pharmaceutical
distribution channels: over-the-counter (OTC), prescription and hospital. Our product
portfolio comprises both proprietary and in-licensed products, and includes patented,
branded and generic drugs. Our business model is to develop and in-license products
for sale by our own dedicated sales teams in our home markets of Australia and New
Zealand and in certain Southeast Asian markets, and to out-license our products to
local licensees and distributors to the rest of the world. For more information:
aftpharm.com